# LSTA (Lisata Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Lisata Therapeutics, Inc. reported $100K in revenue and a net loss of $17.16M for the trailing twelve months ended September 30, 2026 (down 83.0% year over year), with a -22043.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/LSTA
- Markdown: https://convexityos.com/fundamentals/LSTA.md
- SEC CIK: 0000320017
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000320017&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $100K | -83.0% YoY |
| Operating Income | TTM | -$22.04M | -22043.0% margin |
| Net Income | TTM | -$17.16M | -17159.0% net margin |
| Diluted EPS | TTM | -$1.84 | Split-adjusted |
| Free Cash Flow | TTM | -$21.66M | -21662.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $282.7M | Total debt: $2.10M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $170K | $1.00M | $0 | $0 | -- | -- | -- | -- | -- | $35.28M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | $31.14M |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | -- | -- | $4.15M |
| Research & Development | $7.95M | $11.33M | $12.73M | $13.07M | $17.68M | $9.25M | $10.80M | $7.59M | $15.84M | $16.70M |
| Selling, General & Admin | -- | -- | $12.97M | $14.14M | $11.47M | $9.89M | $9.29M | $9.39M | $11.75M | $12.80M |
| Total Operating Expenses | $18.38M | $23.41M | $25.71M | $57.60M | $29.05M | $19.14M | $20.09M | $16.99M | $27.59M | $29.50M |
| **Operating Income** | -$18.21M | -$22.41M | -$25.71M | -$57.60M | -$29.05M | -$19.14M | -$20.09M | -$16.99M | -$27.59M | -$29.50M |
| **EBITDA** | -$18.06M | -$22.23M | -$25.52M | -$57.53M | -$29.00M | -$19.05M | -$19.99M | -$16.79M | -$27.19M | -$29.00M |
| Interest Expense | -- | -- | -- | -- | -- | -- | $0 | $5.0K | $378K | $1.78M |
| Income Before Tax | -$17.55M | -$20.78M | -$23.17M | -$56.70M | -$28.97M | -$19.01M | -$19.35M | -$16.17M | -$27.70M | -$31.26M |
| Income Tax Expense | -$962K | -$798K | -$2.33M | -$2.48M | -$1.51M | -$10.87M | $0 | $0 | -$11.53M | $0 |
| **Net Income** | -$16.59M | -$19.98M | -$20.84M | -$54.23M | -$27.47M | -$8.15M | -$19.36M | -$16.17M | $22.98M | -$32.66M |
| Basic EPS | -$1.91 | -$2.40 | -$2.58 | -$10.47 | -$7.45 | -$0.99 | -$3.52 | -$3.13 | $4.80 | -$9.35 |
| **Diluted EPS** | -$1.91 | -$2.40 | -$2.58 | -$10.47 | -$7.45 | -$0.99 | -$3.52 | -$3.13 | $4.80 | -$9.35 |
| Basic Shares Outstanding | 8.7M | 8.3M | 8.1M | 5.2M | 3.7M | 8.2M | 5.5M | 5.2M | 4.8M | 3.5M |
| Diluted Shares Outstanding | 8.7M | 8.3M | 8.1M | 5.2M | 3.7M | 8.2M | 5.5M | 5.2M | 4.8M | 3.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $100K | $0 | $70K | $0 | $1.00M |
| Research & Development | $5.21M | $584K | $1.20M | $1.13M | $1.96M | $2.25M | $2.60M | $2.95M |
| Selling, General & Admin | -- | -- | -- | -- | $2.46M | $2.69M | $3.25M | -- |
| Total Operating Expenses | $10.03M | $3.99M | $4.94M | $3.18M | $4.41M | $4.94M | $5.85M | $5.95M |
| **Operating Income** | -$10.03M | -$3.99M | -$4.94M | -$3.08M | -$4.41M | -$4.87M | -$5.85M | -$4.95M |
| **EBITDA** | -$10.03M | -$3.99M | -$4.94M | -$3.06M | -$4.37M | -$4.82M | -$5.80M | -$4.91M |
| Income Before Tax | -$12.81M | -$2.93M | -$4.88M | -$2.95M | -$4.25M | -$4.66M | -$5.69M | -$4.61M |
| Income Tax Expense | -$6.03M | $0 | -$387K | $0 | $0 | $0 | -$962K | $0 |
| **Net Income** | -$6.79M | -$2.93M | -$4.49M | -$2.95M | -$4.25M | -$4.66M | -$4.72M | -$4.61M |
| Basic EPS | -$0.73 | -$0.32 | -$0.50 | -- | -$0.49 | -$0.54 | -$0.55 | -- |
| **Diluted EPS** | -$0.73 | -$0.32 | -$0.50 | -- | -$0.49 | -$0.54 | -$0.55 | -- |
| Basic Shares Outstanding | 9.3M | 9.1M | 9.0M | -- | 8.7M | 8.6M | 8.6M | -- |
| Diluted Shares Outstanding | 9.3M | 9.1M | 9.0M | -- | 8.7M | 8.6M | 8.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15.96M | $16.21M | $22.59M | $32.15M | $24.65M | $16.51M | $14.03M | $10.30M | $29.16M | $7.08M |
| **Cash & Short-Term Investments** | $15.96M | $25.65M | $44.66M | $64.74M | $91.45M | $30.74M | $22.77M | $37.82M | $51.88M | $4.43M |
| Accounts Receivable, Net | $0 | $900K | $0 | -- | -- | -- | -- | -- | $234K | $139K |
| **Total Current Assets** | $17.70M | $34.58M | $53.92M | $71.88M | $96.18M | $35.33M | $25.97M | $44.11M | $61.40M | $24.65M |
| Property, Plant & Equipment, Net | $18K | $72K | $175K | $296K | $62K | $57K | $100K | $165K | $257K | $705K |
| Goodwill | $0 | -- | -- | -- | -- | -- | -- | -- | -- | $7.01M |
| Intangible Assets | $0 | $400K | $400K | $400K | $0 | -- | -- | -- | -- | $2.31M |
| Other Non-Current Assets | $23K | $160K | $332K | $528K | $764K | $614K | $1.08M | $309K | $1.72M | $1.58M |
| **Total Non-Current Assets** | $41K | $424K | $770K | $1.16M | $826K | $671K | $1.18M | $474K | $1.98M | $28.87M |
| **Total Assets** | $17.74M | $35.00M | $54.69M | $73.03M | $97.01M | $36.00M | $27.15M | $44.58M | $63.38M | $53.51M |
| Accounts Payable | $1.02M | $1.28M | $2.42M | $2.65M | $1.93M | $1.02M | $1.49M | $762K | $1.34M | $2.23M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $3.13M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $2.58M | $2.45M | $5.10M |
| **Total Current Liabilities** | $3.07M | $5.61M | $6.59M | $6.38M | $4.52M | $3.51M | $5.98M | $5.62M | $9.31M | $21.18M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $2.52M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $4.59M |
| Other Non-Current Liabilities | $72K | $72K | $210K | $327K | $485K | $254K | $624K | $1.51M | $3.87M | $390K |
| **Total Non-Current Liabilities** | $72K | $72K | $210K | $327K | $485K | $254K | $624K | $1.51M | $3.87M | $28.37M |
| **Total Liabilities** | $3.14M | $5.68M | $6.80M | $6.71M | $5.01M | $3.76M | $6.60M | $7.13M | $13.19M | $30.05M |
| **Total Debt (incl. Leases)** | -- | $137K | $305K | $485K | $714K | $624K | $977K | -- | $0 | $5.65M |
| Common Stock | $9.0K | $8.0K | $8.0K | $8.0K | $4.0K | $19K | $11K | $10K | $9.0K | $8.2K |
| Retained Earnings | -$564.7M | -$548.1M | -$528.1M | -$507.2M | -$453.0M | -$425.6M | -$417.4M | -$398.0M | -$381.8M | -$404.8M |
| Accumulated Other Comp. Income | -$37K | -$81K | -$42K | -$29K | -$70K | -$13K | $2.0K | -$32K | -$28K | $0 |
| **Total Stockholders' Equity** | $14.86M | $29.57M | $48.15M | $66.58M | $92.25M | $32.50M | $20.82M | $37.73M | $50.51M | $4.88M |
| Total Equity | $14.60M | $29.32M | $47.89M | $66.32M | $92.00M | $32.24M | $20.55M | $37.45M | $50.19M | $4.07M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $282.7M | $10.44M | $13.06M | $15.96M | $19.00M | $16.84M | $20.22M | $16.21M |
| **Cash & Short-Term Investments** | $282.7M | $10.44M | $13.06M | $15.96M | $14.49M | $17.25M | $22.98M | $25.65M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $502K | $501K | $750K | $900K |
| **Total Current Assets** | $287.8M | $11.01M | $14.02M | $17.70M | $21.57M | $24.89M | $28.62M | $34.58M |
| Property, Plant & Equipment, Net | $177K | $14K | $16K | $18K | $22K | $48K | $74K | $72K |
| Goodwill | $64.73M | -- | -- | $0 | -- | -- | -- | -- |
| Intangible Assets | $292.9M | $400K | $400K | $0 | $400K | $400K | $400K | $400K |
| Other Non-Current Assets | $2.85M | $0 | $23K | $23K | $23K | $70K | $116K | $160K |
| **Total Non-Current Assets** | $360.7M | $14K | $39K | $41K | $184K | $275K | $364K | $424K |
| **Total Assets** | $648.4M | $11.03M | $14.06M | $17.74M | $21.76M | $25.16M | $28.98M | $35.00M |
| Accounts Payable | $6.57M | $836K | $510K | $1.02M | $619K | $782K | $602K | $1.28M |
| **Total Current Liabilities** | $20.42M | $2.99M | $3.31M | $3.07M | $4.57M | $4.31M | $3.81M | $5.61M |
| Other Non-Current Liabilities | $6.92M | $50K | $72K | $72K | $72K | $72K | $72K | $72K |
| **Total Non-Current Liabilities** | $36.35M | $50K | $72K | $72K | $72K | $72K | $72K | $72K |
| **Total Liabilities** | $56.77M | $3.04M | $3.39M | $3.14M | $4.64M | $4.38M | $3.88M | $5.68M |
| **Total Debt (incl. Leases)** | $2.10M | -- | -- | -- | -- | $47K | $92K | $137K |
| Common Stock | $11K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K |
| Retained Earnings | -$578.9M | -$572.1M | -$569.1M | -$564.7M | -$561.7M | -$557.4M | -$552.8M | -$548.1M |
| Accumulated Other Comp. Income | $9.0K | -$17K | -$21K | -$37K | -$42K | -$50K | -$78K | -$81K |
| **Total Stockholders' Equity** | $7.64M | $8.24M | $10.93M | $14.86M | $17.37M | $21.03M | $25.36M | $29.57M |
| Total Equity | $7.64M | $7.99M | $10.67M | $14.60M | $17.12M | $20.77M | $25.10M | $29.32M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$16.59M | -$19.98M | -$20.84M | -$54.23M | -$27.47M | -$8.14M | -$19.35M | -$16.17M | $22.23M | -$33.31M |
| Depreciation & Amortization | $146K | $174K | $189K | $69K | $55K | $100K | $100K | $200K | $400K | $500K |
| Stock-Based Compensation | $1.23M | $1.65M | $2.04M | $2.64M | $2.00M | $1.26M | $1.29M | $2.45M | $2.85M | $2.60M |
| Change in Receivables | $401K | -$900K | $0 | -- | -- | -- | -- | -- | -$96K | -$102K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$671K |
| **Operating Cash Flow** | -$15.95M | -$19.36M | -$20.03M | -$21.17M | -$22.25M | -$8.82M | -$18.88M | -$19.99M | -$20.88M | -$23.67M |
| Capital Expenditure | -$28K | $0 | $0 | -$285K | -$60K | -$20K | $0 | -$134K | -$135K | -$1.10M |
| **Free Cash Flow** | -$15.98M | -$19.36M | -$20.03M | -$21.45M | -$22.30M | -$8.84M | -$18.88M | -$20.12M | -$21.01M | -$24.77M |
| Purchases of Investments | -$9.18M | -$55.69M | -$98.48M | -$89.69M | -$179.8M | -$34.80M | -$32.94M | -$69.69M | -$60.16M | $0 |
| **Investing Cash Flow** | $15.09M | $13.23M | $10.10M | $28.91M | -$54.90M | -$7.28M | $21.43M | -$4.71M | $41.27M | -$2.85M |
| Common Stock Issued | $844K | $68K | $321K | $43K | $85.50M | $18.73M | $1.31M | $1.03M | $5.70M | $11.56M |
| **Financing Cash Flow** | $599K | -$206K | $385K | -$224K | $85.28M | $18.58M | $1.18M | $824K | -$932K | $20.90M |
| **Net Change in Cash** | -$253K | -$6.38M | -$9.56M | $7.51M | $8.13M | $2.48M | $3.73M | -$23.87M | $19.46M | -$5.61M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.79M | -$2.93M | -$4.49M | -$2.95M | -$4.25M | -$4.66M | -$4.72M | -$4.61M |
| Depreciation & Amortization | $3.0K | $3.0K | $2.0K | $15K | $44K | $44K | $43K | $41K |
| Stock-Based Compensation | $552K | $214K | $364K | $225K | $232K | $239K | $530K | $635K |
| Change in Receivables | $0 | $0 | $0 | $3.0K | -$1.0K | $249K | $150K | -$900K |
| **Operating Cash Flow** | -$12.68M | -$2.65M | -$3.08M | -$3.25M | -$3.34M | -$3.96M | -$5.40M | -$4.53M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -$28K | $0 |
| **Free Cash Flow** | -$12.68M | -$2.65M | -$3.08M | -$3.25M | -$3.34M | -$3.96M | -$5.43M | -$4.53M |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | -$4.12M | -$5.05M | -$11.73M |
| **Investing Cash Flow** | $72.92M | $0 | $0 | $0 | $5.15M | $505K | $9.43M | $1.39M |
| Common Stock Issued | $0 | $29K | $0 | $205K | $353K | $74K | $212K | $36K |
| **Financing Cash Flow** | $212.1M | $29K | $181K | $205K | $353K | $64K | -$23K | -$96K |
| **Net Change in Cash** | $272.3M | -$2.62M | -$2.90M | -$3.04M | $2.16M | -$3.38M | $4.01M | -$3.30M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | -- | -- | 11.8% |
| **Operating Margin** | -10711.2% | -2240.9% | -- | -- | -- | -- | -- | -- | -- | -83.6% |
| **Net Profit Margin** | -9756.5% | -1998.5% | -- | -- | -- | -- | -- | -- | -- | -92.6% |
| Return on Equity (ROE) | -111.7% | -67.6% | -43.3% | -81.4% | -29.8% | -25.1% | -93.0% | -42.9% | 45.5% | -668.7% |
| Return on Assets (ROA) | -93.5% | -57.1% | -38.1% | -74.2% | -28.3% | -22.6% | -71.3% | -36.3% | 36.3% | -61.0% |
| Current Ratio | 5.76x | 6.16x | 8.18x | 11.26x | 21.27x | 10.08x | 4.35x | 7.85x | 6.59x | 1.16x |
| Quick Ratio | 5.20x | 4.73x | 6.78x | 10.14x | 20.22x | 8.77x | 3.81x | 6.73x | 5.60x | 0.22x |
| Debt to Equity | -- | 0.00x | 0.01x | 0.01x | 0.01x | 0.02x | 0.05x | -- | 0.00x | 1.16x |
| **Revenue Growth (YoY)** | -83.0% | -- | -- | -- | -- | -- | -- | -- | -- | +56.9% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | +78.1% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -170.4% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -165.2% | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -318.1% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -22043.0% | -16427.0% | -10178.2% | -10710.6% | -1876.4% | -1962.6% | -2165.5% | -2240.9% |
| **Net Profit Margin** | -17159.0% | -14621.0% | -9618.2% | -9756.5% | -1704.9% | -1768.5% | -1930.8% | -1998.5% |
| Return on Equity (ROE) | -224.5% | -177.4% | -149.7% | -111.7% | -105.0% | -90.0% | -76.1% | -67.6% |
| Return on Assets (ROA) | -2.6% | -132.6% | -116.3% | -93.5% | -83.8% | -75.2% | -66.6% | -57.1% |
| Current Ratio | 14.09x | 3.69x | 4.23x | 5.76x | 4.72x | 5.77x | 7.52x | 6.16x |
| Quick Ratio | 13.85x | 3.50x | 3.94x | 5.20x | 3.28x | 4.12x | 6.23x | 4.73x |
| Debt to Equity | 0.28x | -- | -- | -- | -- | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -90.0% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
